Daxor Long Term Debt 2010-2011 | DXR

Daxor long term debt from 2010 to 2011. Long term debt can be defined as the sum of all long term debt fields.
Daxor Annual Long Term Debt
(Millions of US $)
2011 $0
2010 $0
2009 $0
Daxor Quarterly Long Term Debt
(Millions of US $)
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.042B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.757B 19.47
Encompass Health (EHC) United States $12.036B 25.51
DaVita (DVA) United States $10.432B 14.67
Chemed (CHE) United States $8.030B 25.24
Elanco Animal Health (ELAN) United States $7.087B 15.18
Option Care Health (OPCH) United States $5.189B 23.13
RadNet (RDNT) United States $4.342B 275.57
Amedisys (AMED) United States $3.180B 21.39
LifeStance Health (LFST) United States $2.178B 0.00
Addus HomeCare (ADUS) United States $2.073B 22.77
Astrana Health (ASTH) United States $1.478B 36.61
U.S Physical Therapy (USPH) United States $1.187B 30.65
Aveanna Healthcare Holdings (AVAH) United States $1.024B 58.33
Pennant (PNTG) United States $0.953B 35.00
Atai Life Sciences (ATAI) Germany $0.447B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.047B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00